SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

Rebecca Coll; Luke A.J. O'Neill; Matthew A Cooper; Avril A B Robertson; Kate Schroder

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

Rebecca Coll (Inventor), Luke A.J. O'Neill (Inventor), Matthew A Cooper (Inventor), Avril A B Robertson (Inventor), Kate Schroder (Inventor)

School of Medicine, Dentistry and Biomedical Sciences

Research output: Patent

Abstract

The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.

Original language	English
Patent number	PCT/AU2016/050103
Priority date	16/02/2015
Filing date	16/02/2016
Publication status	Published - 25 Aug 2016

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016131098

Cite this

@misc{aaa0aba7e9ed44e38fcbe7912ea7226b,

title = "SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME",

abstract = "The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.",

author = "Rebecca Coll and O'Neill, {Luke A.J.} and Cooper, {Matthew A} and Robertson, {Avril A B} and Kate Schroder",

year = "2016",

month = aug,

day = "25",

language = "English",

type = "Patent",

note = "PCT/AU2016/050103",

}

TY - PAT

T1 - SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

AU - Coll, Rebecca

AU - O'Neill, Luke A.J.

AU - Cooper, Matthew A

AU - Robertson, Avril A B

AU - Schroder, Kate

PY - 2016/8/25

Y1 - 2016/8/25

N2 - The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.

AB - The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.

M3 - Patent

M1 - PCT/AU2016/050103

Y2 - 2016/02/16

ER -

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

Abstract

Access to Document

Fingerprint

Cite this